Newspaper article St Louis Post-Dispatch (MO)

Colvin, O. Michael Died Peacefully Saturday Evening

Newspaper article St Louis Post-Dispatch (MO)

Colvin, O. Michael Died Peacefully Saturday Evening

Article excerpt

Colvin, O. Michael died peacefully Saturday evening, March 16, 2013. Mike was born in Princeton, Indiana, on June 15, l936, the only child of Jack and Evelyn Colvin. Mike graduated from Princeton High School in 1954, Indiana University in 1957 and Washington University School of Medicine in St. Louis in 1961. He did his internship and residency in internal medicine at Johns Hopkins University. After two years as a fellow at the National Cancer Institute, he worked at Johns Hopkins for the next 30 years. He was Professor of Medicine and Pharmacology and Director of the internationally recognized Division of Pharmacology and Experimental Therapeutics for the Oncology Center. He also served as Research Director of the Oncology Center and Associate Dean for Research for the Medical School. In 1995, he became Director of the Duke University Comprehensive Cancer Center. Mike was named the William W. Shingleton Professor of Cancer Research and Professor of Pharmacology and Cancer Biology. He served as Director until 2002, leading the Cancer Center through a period of significant growth and scientific achievement. Mike retired from Duke in 2008 as Professor Emeritus of Medicine. Mike was a prominent cancer researcher, publishing several hundred journal articles, book chapters and abstracts and holding five patents. He did pioneering work establishing the mechanism of action of several drugs, including cyclophosphamide, one of the first and most commonly used anticancer agents. He was one of the first investigators to use high dose cyclophosphamide to treat solid tumors, now a common practice in bone marrow transplantation for breast and other cancers. His work contributed to the development of current stem cell therapies. He served on the Executive Board of the American Association of Cancer Research and on the Advisory Board of the National Institutes of Heath Center for Scientific Review, which oversees NIH grant review and funding. He was co-editor of the journal Molecular Cancer Therapeutics and served on the advisory boards of several cancer centers, including that of his medical school alma mater. He received numerous honors, including election to Phi Beta Kappa, Alpha Omega Alpha and the Association of American Physicians. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.